Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT), most recent 12 months reported: revenue $336.11K, net loss $4.75M. Latest balance sheet on file: liquid cash $1.16M, total debt $3.4M, net cash -$2.25M. From SEC filings. Others in Pharmaceutical Preparations: YARROW BIOSCIENCE, INC. · Quantum Cyber N.V. · MEREO BIOPHARMA GROUP PLC · Can-Fite BioPharma Ltd. · CervoMed Inc. · Allarity Therapeutics, Inc. · REGEN BIOPHARMA, INC. · Clene Inc.

Stock screener

Watchlist